- Home
- EPSM vs SCNX Comparison
EPSM vs SCNX Comparison
Compare EPSM & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPSM | SCNX |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | China | United States |
| Employees | 13 | 19 |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.9M | 19.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EPSM | SCNX |
|---|---|---|
| Price | $1.42 | $0.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 12.3K | ★ 703.8K |
| Earning Date | 05-24-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $1,097.38 |
| Revenue Next Year | N/A | $239.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $0.24 |
| 52 Week High | $155.00 | $2.60 |
Technical Indicators
Market Signals| Indicator | EPSM | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 46.49 | 54.20 |
| Support Level | $1.31 | $0.38 |
| Resistance Level | $1.69 | $0.48 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 21.05 | 78.59 |
Price Performance
Historical ComparisonAbout EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.